Lysosomal enzymes, cathepsins in brain tumour invasion

Journal of Neuro-Oncology

Volumn 58, Issue 1, 2002, Pages 21-32

  Levicar N ^a   Strojnik, T ^b   Kos, J ^a,c,d   Dewey, R A ^e   Pilkington, G J ^e   Lah, T T ^a  

^a NATIONAL INSTITUTE OF BIOLOGY   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

^c JO EF STEFAN INSTITUTE   (Slovenia)

^d Department of Biochemical Research and Drug Design ^*  (Slovenia)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Angiogenesis; Cathepsins; Cystatins; Glioma; Invasion; Meningioma; Stefins

Indexed keywords

ASPARTIC PROTEINASE; BIOLOGICAL MARKER; CATHEPSIN; CATHEPSIN B; CATHEPSIN D; CATHEPSIN H; CATHEPSIN L; CATHEPSIN S; COLLAGEN TYPE 4; CYSTATIN; CYSTATIN C; CYSTEINE PEPTIDASE INHIBITOR; CYSTEINE PROTEINASE; ENZYME INHIBITOR; FIBRONECTIN; KININOGEN; LAMININ; LYSOSOME ENZYME; MATRIGEL; PROTEIN ANTIBODY; SCLEROPROTEIN; STEFIN; STEFIN A; STEFIN B; UNCLASSIFIED DRUG;

ASTROCYTOMA; BENIGN TUMOR; BRAIN TUMOR; CANCER GRADING; CANCER INHIBITION; CANCER INVASION; CELL LEVEL; CENTRAL NERVOUS SYSTEM TUMOR; COMPARATIVE STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE MARKER; DRUG RESEARCH; DRUG TARGETING; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME RELEASE; ENZYME STRUCTURE; ENZYME SYNTHESIS; EVIDENCE BASED MEDICINE; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; MALIGNANT MENINGIOMA; MENINGIOMA; PATHOGENESIS; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; TISSUE LEVEL; TUMOR BIOPSY;

ANIMALS; BRAIN NEOPLASMS; CATHEPSINS; ENZYMES; HUMANS; LYSOSOMES; NEOPLASM INVASIVENESS;

EID: 0036294944     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015892911420     Document Type: Review

References (73)

1. World Health Organization Classification of Tumours
2. The role of proteolytic enzymes in brain tumour infiltration
3. Processes of glioma invasion
4. Proliferative properties of malignant brain tumors
5. Glioma cell invasion studied in organotypic coculture models
6. The paradox of neoplastic glial cell invasion of the brain and apparent metastatic failure
7. Meningiomas: Behavior in vivo and in vitro
8. Meningiomas
9. Interface between the meningioma and the brain
10. Cathepsins B and L are markers for clinically invasive types of meningiomas
11. Overview - Burgeoning promise in metastasis research
12. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
13. MEROPS: The peptidase database
14. Regulation of lysosomal endopeptidases in malignant neoplasia
15. Proteases as prognostic markers in cancer. Minireview
16. Cysteine proteinases and their endogenous inhibitors: Target proteins for prognosis, diagnosis and therapy in cancer
17. Tumour-associated proteases
18. Unraveling the role of proteases in cancer
19. Lysosomal cysteine proteases: More than scavengers
20. Endocytosis of pro-cathepsin D into breast cancer cells is mostly independent of mannose-6-phosphate receptors
21. Molecular regulation, membrane association and secretion of tumour cathepsin B
22. Cathepsin B and glioma invasion
23. Degradation of laminin by human tumour cathepsin B
24. Degradation of extracellular matrix proteins by human cathepsin B from normal and tumour tissues
25. Autocatalytic processing of recombinant human procathepsin B is a bimolecular process
26. Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells
27. Cysteine proteases and tumour progression
28. Characterisation of the cathepsin B gene and multiple RNAs in human tissues: Evidence for alternative splicing of cathepsin B pre-mRNA
29. Sequence analysis and distribution of two new human cathepsin L splicing variants
30. Cathepsin D in breast cancer: Mechanisms and clinical applications, a 1999 overview
31. Cysteine proteinases in cancer progression and their clinical relevance for prognosis
32. Prognostic values of cathepsin B and carcioembrionic antigen in sera of patients with colorectal carcinoma
33. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients
34. Mice defficient for the lysosomal proteinase cathepsin exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells
35. Activation of astrocytic lysosomal proteinase by factors released by mononuclear leukocytes
36. A cellular stress model for the differential expression of glial lysomal cathepsins in the ageing nervous system
37. Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles
38. Regulation of a novel pathway for cell death by lysosomal aspartic and cysteine proteinases
39. Immunolocalization of cathepsin D in the human central nervous system and central nervous system neoplasms
40. The characterisation of nuclear DNA content, the proliferative activity and the immunohistochemical expression of GFAP, VIM, LEU-7, S-100, p53 and cathepsin D in human glioblastoma multiformes (hGBMs) versus human GBM cell lines grafted into brains of nude mice
41. Expression of cathepsin D during the progression of human gliomas
42. Expression of adhesion factors and degrading proteins in primary and secondary glioblastoma and their precursor tumors
43. Expression of cathepsin D in human astrocytic neoplasias
44. Thyropins - New structurally related proteinase inhibitors
45. Emerging roles for cysteine proteases in human biology
46. Evidence for extracellular acting cathepsins mediating thyroid hormone liberation in thyroid epithelial cells
47. Cathepsin B efficiently inactivates the soluble and tumour cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (pro-uPA)
48. Mammalian cysteine proteinase inhibitors: Biochemical properties and possible role in tumour progression
49. Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene
50. Retinoic acid alters the intracellular trafficking of the mannose-6-phosphate/insulin-like growth factor II receptor and lysosomal enzymes
51. Differential regulation of cathepsins D, B and L in transformed human breast epithelial cells (HBEC) with increased invasiveness
52. Detection of lysosomal cysteine proteinases in microglia: Flow cytometric measurements and histochemical localization of cathepsins B and L
53. Microglial cathepsin B: An immunological examination of cellular and secreted species
54. Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease
55. Enyzmatically active lysosomal proteases are associated with amyloid deposits in Alzheimer's brain
56. The lysosomal cysteine proteasse cathepsin S is increased in Alzheimer's disease and Down syndrome brain
57. Secretion of Cat B by human gliomas in vitro
58. Cathepsin B expression and localization in glioma progression and invasion
59. Overexpression and localization of Cat B during the progression of human gliomas
60. Immunolocalization of Cat B in human glioma: Implications for tumour invasion and angiogenesis
61. Cathepsin B immunohistochemical staining in tumour and endothelial cells is a new prognostic factor for survival in patients with brain tumors
62. Clinical and experimental studies of cysteine cathepsins and their inhibitors in human brain tumors
63. Full length cathepsin L antisense RNA induces downregulation of its protein levels, inhibiting brain tumour invasion in vitro
64. Binding of the cysteine proteinases papain and cathepsin B-like to coated laminin: Use of synthetic peptides from laminin and from laminin binding region of the beta 1 integrin subunit to characterize the binding site
65. Extracellular matrix-modulated differential invasion of human meningioma cell lines in vitro
66. Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas
67. Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumour malignancy and involves a metalloproteolytic activity
68. Expression and the role of cathepsin H in human glioma progression and invasion
69. Extracellular cathepsin S activity is increased in high grade astrocytoma in vitro
70. Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells
71. Stefins and lysosomal cathepsins B, L and D in human breast carcinoma
72. Differential localization of cysteine protease inhibitors and a target cysteine protease cathepsin B by immuno-confocal microscopy
73. Expression of cysteine protease inhibitors in human gliomas and meningiomas